Nikolas Klein

Summary

Country: Austria

Publications

  1. ncbi request reprint Therapy of treatment resistant depression: focus on the management of TRD with atypical antipsychotics
    Nikolas Klein
    Department of General Psychiatry, Medical University of Vienna, A 1090 Vienna, Austria
    CNS Spectr 9:823-32. 2004
  2. doi request reprint Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram
    Siegfried Kasper
    Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
    Int Clin Psychopharmacol 24:119-25. 2009
  3. ncbi request reprint Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT study
    Nikolas Klein
    Department of General Psychiatry, Medical University of Vienna, Wahringer Gurtel 18 20, 1090, Vienna, Austria
    Psychopharmacology (Berl) 191:333-9. 2007
  4. ncbi request reprint Effects of olanzapine and ziprasidone on glucose tolerance in healthy volunteers
    Julia Sacher
    Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
    Neuropsychopharmacology 33:1633-41. 2008
  5. ncbi request reprint Reduced serotonin-1A receptor binding in social anxiety disorder
    Rupert R Lanzenberger
    Department of General Psychiatry, Medical University of Vienna, Vienna, Austria
    Biol Psychiatry 61:1081-9. 2007
  6. ncbi request reprint Striatal D(2) receptor occupancy in bipolar patients treated with olanzapine
    Trawat Attarbaschi
    Department of General Psychiatry, Medical University Vienna, Vienna, Austria
    Eur Neuropsychopharmacol 17:102-7. 2007

Detail Information

Publications6

  1. ncbi request reprint Therapy of treatment resistant depression: focus on the management of TRD with atypical antipsychotics
    Nikolas Klein
    Department of General Psychiatry, Medical University of Vienna, A 1090 Vienna, Austria
    CNS Spectr 9:823-32. 2004
    ..This review especially focuses on the augmentation of the antidepressant therapy with atypical antipsychotics...
  2. doi request reprint Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram
    Siegfried Kasper
    Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
    Int Clin Psychopharmacol 24:119-25. 2009
    ....
  3. ncbi request reprint Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT study
    Nikolas Klein
    Department of General Psychiatry, Medical University of Vienna, Wahringer Gurtel 18 20, 1090, Vienna, Austria
    Psychopharmacology (Berl) 191:333-9. 2007
    ..In the present study, the occupancies of SERT after multiple doses of escitalopram and citalopram were compared using the radioligand [(123)I]ADAM and single photon emission computed tomography (SPECT)...
  4. ncbi request reprint Effects of olanzapine and ziprasidone on glucose tolerance in healthy volunteers
    Julia Sacher
    Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
    Neuropsychopharmacology 33:1633-41. 2008
    ..Our finding is suggestive that not all atypical antipsychotics cause acute direct effects on glucose disposal and that accurate determination of side effect profile should be performed when choosing an atypical antipsychotic...
  5. ncbi request reprint Reduced serotonin-1A receptor binding in social anxiety disorder
    Rupert R Lanzenberger
    Department of General Psychiatry, Medical University of Vienna, Vienna, Austria
    Biol Psychiatry 61:1081-9. 2007
    ..The objective of this study was to investigate 5-HT1A receptor binding potential (BP) in social anxiety disorder (SAD)...
  6. ncbi request reprint Striatal D(2) receptor occupancy in bipolar patients treated with olanzapine
    Trawat Attarbaschi
    Department of General Psychiatry, Medical University Vienna, Vienna, Austria
    Eur Neuropsychopharmacol 17:102-7. 2007
    ..Although we did not find an increased vulnerability for acute EPS in bipolar patients receiving olanzapine at clinical relevant doses, this needs to be replicated with larger sample sizes...